Murat Cakır
Yozgat, 66200, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Selective CB2 Agonist JWH-133 Suppresses Viability and Migration-Related Responses in Prostate Cancer Cells.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 10, 2026
Pharmacologic Activation of TRPA1 Induces Multi-Target Anticancer Responses via Apoptotic and Mitochondrial Pathways.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 09, 2026
Bilateral and Unilateral Renal Ischemia-Reperfusion Injury Model in Rats.
Journal: Current protocols
Published: October 08, 2025
The ameliorative effect of inhibiting transient receptor potential ankyrin 1 on sepsis-induced kidney injury via the toll-like receptor 4/nuclear factor-kappa B pathway.
Journal: European journal of pharmacology
Published: May 30, 2025
The Effect of Sulfasalazine on Renal Damage in Sepsis Model Induced by Cecal Ligation and Puncture in Rats.
Journal: Journal of biochemical and molecular toxicology
Published: April 13, 2025
Protective Effects of TRPV1 Agonist Capsaicin in Sepsis-Induced Acute Kidney Injury in Rats.
Journal: Journal of biochemical and molecular toxicology
Published: January 15, 2025
JAK1/JAK2 inhibitor baricitinib ameliorates sepsis-induced acute kidney injury in rats.
Journal: European journal of pharmacology
Published: November 26, 2024
Protective Effect of Transient Receptor Potential Ankyrin 1 Inhibition on Renal Ischemia Reperfusion Injury in Rats.
Journal: Journal of biochemical and molecular toxicology
Published: October 25, 2024
The relationship of salusins with Parkinson's Disease, Alzheimer's Disease, and acute ischemic stroke: A preliminary study.
Journal: Neuroscience letters
Published: October 23, 2023
Neuroprotective effect of transient receptor potential Vanilloid 1 agonist capsaicin in Alzheimer's disease model induced with okadaic acid.
Journal: International immunopharmacology
Published: December 23, 2022
Protective effect of fatty acid amide hydrolase inhibitor URB597 and monoacylglycerol lipase inhibitor KML29 on renal ischemia-reperfusion injury via toll-like receptor 4/nuclear factor-kappa B pathway.
Journal: International immunopharmacology
Published: September 05, 2022
Adropin and MOTS-c as new peptides: Do levels change in neurodegenerative diseases and ischemic stroke?
Journal: Journal of biochemical and molecular toxicology
Published: March 27, 2022
Last Updated: 09/26/2026